Maravai LifeSciences Holdings Non-GAAP EPS of -$0.08 misses by $0.01, revenue of $47.4M in-line [Seeking Alpha]
Maravai LifeSciences Holdings, Inc. - Class A common stock (MRVI)
Company Research
Source: Seeking Alpha
More on Maravai LifeSciences Holdings Maravai LifeSciences Holdings Q2 2025 Earnings Preview Maravai LifeSciences appoints Bernd Brust as CEO Seeking Alpha's Quant Rating on Maravai LifeSciences Holdings Historical earnings data for Maravai LifeSciences Holdings Financial information for Maravai LifeSciences Holdings Recommended For You Comments More Trending News
Show less
Read more
Impact Snapshot
Event Time:
MRVI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRVI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRVI alerts
High impacting Maravai LifeSciences Holdings, Inc. - Class A common stock news events
Weekly update
A roundup of the hottest topics
MRVI
News
- Maravai LifeSciences (NASDAQ:MRVI) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.MarketBeat
- Why Analysts See Opportunity and Risk as Maravai's Story Evolves After Management Shakeup [Yahoo! Finance]Yahoo! Finance
- CEO & Director of Maravai LifeSciences Holdings Picks Up 13% More Stock [Yahoo! Finance]Yahoo! Finance
- Maravai LifeSciences Announces November 2025 Investor Conference ScheduleBusiness Wire
- Maravai LifeSciences Reports Third Quarter 2025 Financial ResultsBusiness Wire
MRVI
Earnings
- 11/6/25 - In-Line
MRVI
Sec Filings
- 12/23/25 - Form 144
- 12/19/25 - Form 144
- 12/9/25 - Form 4
- MRVI's page on the SEC website